These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 11361480

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A look ahead at this year's drug approvals.
    Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824
    [No Abstract] [Full Text] [Related]

  • 25. The QUEST trial, a paradigm of HIV collaborative research.
    Goh LE, McDade H, Kinloch S, Perrin L, Cooper D, Phillips A, Hoen B, Autran B, Sonnerborg A, Tsoukas C.
    Nat Med; 2000 Nov; 6(11):1194. PubMed ID: 11062508
    [No Abstract] [Full Text] [Related]

  • 26. On approval.
    Huff B.
    GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
    [No Abstract] [Full Text] [Related]

  • 27. FDA approves Viread for HIV-1 infection.
    FDA Consum; 2002 Oct; 36(1):5. PubMed ID: 11881601
    [No Abstract] [Full Text] [Related]

  • 28. FDA gives salvage therapy testing a push forward.
    Bass E.
    AIDS Treat News; 2001 Mar 23; (362):3-7, 1. PubMed ID: 11569956
    [Abstract] [Full Text] [Related]

  • 29. Emerging drugs in the fight against HIV disease.
    Rosenthal E.
    HRSA Careaction; 2003 Feb 23; ():1-8. PubMed ID: 12739497
    [No Abstract] [Full Text] [Related]

  • 30. Viread gets FDA nod.
    Rodriquez E.
    Posit Living; 2003 Feb 23; 10(7):33. PubMed ID: 11808509
    [No Abstract] [Full Text] [Related]

  • 31. Generic nucleoside approved.
    AIDS Patient Care STDS; 2005 Aug 23; 19(8):540. PubMed ID: 16163787
    [No Abstract] [Full Text] [Related]

  • 32. FDA notifications. Reyataz is approved for HIV treatment.
    AIDS Alert; 2003 Sep 23; 18(9):119-20. PubMed ID: 14686309
    [Abstract] [Full Text] [Related]

  • 33. FDA grants tentative approval to first generic version of antiretroviral Viread.
    AIDS Patient Care STDS; 2008 Jan 23; 22(1):86. PubMed ID: 18453039
    [No Abstract] [Full Text] [Related]

  • 34. New classes of HIV drugs on the horizon. A review of the presentation at the satellite symposium "New hope: advancing care in HIV infection" at the 15th annual Association of Nurses in AIDS Care conference, November 2002.
    O'Brien WA.
    AIDS Read; 2003 Mar 23; 13(3 Suppl):S4-8. PubMed ID: 12765159
    [Abstract] [Full Text] [Related]

  • 35. Viramune cleared for use in combination with protease inhibitors.
    AIDS Patient Care STDS; 1998 Nov 23; 12(11):872. PubMed ID: 11362046
    [No Abstract] [Full Text] [Related]

  • 36. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
    AIDS Alert; 2006 Jan 23; 21(1):11-2. PubMed ID: 16470945
    [No Abstract] [Full Text] [Related]

  • 37. Is it time to rethink the expanded-access programs for HIV infection?
    Amorosa V, Tebas P.
    J Infect Dis; 2007 Oct 01; 196(7):974-7. PubMed ID: 17763316
    [Abstract] [Full Text] [Related]

  • 38. AIDS 2002: still room for improvement.
    Sharp M.
    Posit Aware; 2002 Oct 01; 13(1):28-9. PubMed ID: 12216527
    [No Abstract] [Full Text] [Related]

  • 39. Opinion paper. Resistance to new anti-HIV agents: problems in the pathway of drug registration.
    Dalmau D, Klimkait T, Telenti A.
    Antivir Ther; 2005 Oct 01; 10(7):867-72. PubMed ID: 16312184
    [Abstract] [Full Text] [Related]

  • 40. Strategies toward restoration of immunity to HIV.
    Autran B.
    AIDS; 2002 Jul 05; 16(10):4-6. PubMed ID: 12146461
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.